The preparation of insoluble, matrix-supported derivatives of asparaginase for use in cancer therapy.
D001215:Asparaginase / Q000302:isolation & purification* / Q000627:therapeutic use; D004926:Escherichia coli / Q000201:enzymology*; D006801:Humans; D008722:Methods; D009369:Neoplasms / Q000188:drug therapy; D012995:Solubility; D013696:Temperature
D001215:Asparaginase